help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pauley, R. J.
Right arrow Articles by Santen, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pauley, R. J.
Right arrow Articles by Santen, R. J.
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 2 837-846
Copyright © 2000 by The Endocrine Society


Original Studies

Regulated CYP19 Aromatase Transcription in Breast Stromal Fibroblasts1

Robert J. Pauley, Steven J. Santner, Larry R. Tait, Robert K. Bright and Richard J. Santen

Barbara Ann Karmanos Cancer Institute (R.J.P., S.J.S., L.R.T., R.K.B.) and the Departments of Internal Medicine (R.J.P.), Pathology (L.R.T.), and Surgery (R.K.B.), Wayne State University School of Medicine, Detroit, Michigan 48201; and University of Virginia Health Sciences Center (R.J.S.), Charlottesville, Virginia 22908

Address all correspondence and requests for reprints to: Robert J. Pauley Ph.D., Barbara Ann Karmanos Cancer Institute, 110 East Warren Avenue, Detroit, Michigan 48201. E-mail: pauleyr{at}kci.wayne.edu

Extraglandular estrogen synthesis mediates the proliferation of estrogen-responsive breast cancer in postmenopausal women. Aromatase, the cytochrome P450 Cyp19 enzyme, catalyzes the rate-limiting step in estrogen biosynthesis. Activity is present in both normal and neoplastic breast tissue, and Cyp19 protein is localized by immunohistochemistry predominantly in breast stromal fibroblasts. In cultured breast stromal fibroblasts, both activity and Cyp19 messenger ribonucleic acid are increased to a substantial degree by hormonal and growth factor regulators of transcription. Transcriptional regulation of CYP19 is complex in breast tissues, in which exon switching in the usage of alternative first exons occurs from predominantly EI.4 in breast tissue from cancer-free women to predominantly EI.3 and PII in breast tumors and quadrants with or without tumor. The present study questioned whether the first exon switch occurs as a result of an inherent difference between fibroblasts in normal and tumor tissues or because of differences in local regulators between these tissues. To distinguish between these two possibilities, we examined fibroblasts cultured from breast tumor, benign breast, and reduction mammoplasty tissues for the ability of various CYP19 transcriptional regulators to modulate first exon EI.3, EI.4, and PII usage. A semiquantitative RT-PCR method was used to identify transcripts containing six of the nine known CYP19 first exons. Combinations of cAMP and Dex regulated transcription from first exons EI.3, EI.4, and PII in fibroblasts cultured from all tissues, but not in reduction mammoplasty epithelial cells. These results provide evidence that the fibroblasts from these breast tissues are not inherently different in transcriptional regulation of CYP19 first exon usage and that transcriptional regulatory molecules are likely to mediate the exon switch phenomenon.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. P.V. Shekhar, B. Gerard, R. J. Pauley, B. O. Williams, and L. Tait
Rad6B Is a Positive Regulator of {beta}-Catenin Stabilization
Cancer Res., March 15, 2008; 68(6): 1741 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. E. Bulun, Z. Lin, G. Imir, S. Amin, M. Demura, B. Yilmaz, R. Martin, H. Utsunomiya, S. Thung, B. Gurates, et al.
Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment
Pharmacol. Rev., September 1, 2005; 57(3): 359 - 383.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Bourguiba, S. Chater, C. Delalande, M. Benahmed, and S. Carreau
Regulation of Aromatase Gene Expression in Purified Germ Cells of Adult Male Rats: Effects of Transforming Growth Factor {beta}, Tumor Necrosis Factor {alpha}, and Cyclic Adenosine 3',5'-Monosphosphate
Biol Reprod, August 1, 2003; 69(2): 592 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. A. Richards and R. W. Brueggemeier
Prostaglandin E2 Regulates Aromatase Activity and Expression in Human Adipose Stromal Cells via Two Distinct Receptor Subtypes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2810 - 2816.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Koblinski, J. Dosescu, M. Sameni, K. Moin, K. Clark, and B. F. Sloane
Interaction of Human Breast Fibroblasts with Collagen I Increases Secretion of Procathepsin B
J. Biol. Chem., August 23, 2002; 277(35): 32220 - 32227.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. P. V. Shekhar, J. Werdell, S. J. Santner, R. J. Pauley, and L. Tait
Breast Stroma Plays a Dominant Regulatory Role in Breast Epithelial Growth and Differentiation: Implications for Tumor Development and Progression
Cancer Res., February 1, 2001; 61(4): 1320 - 1326.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society